Galvanic Vestibular Stimulation as a Novel Treatment for Seasickness

Status Completed

Clinical Trial Summary

subjects with severe seasickness, who failed to habituate to sea conditions after at least six month of active sailing, were enrolled to the single-blind randomized control study. The intervention group was treated with rotatory chair stimulation at sinusoidal harmonic acceleration protocol coupled with galvanic vestibular stimulation to the mastoid processes. This unique procedure was hypothesized to promote habituation to seasickness. The control group underwent a sham procedure. All study participants filled out seasickness questionnaires at set time points following the intervention and underwent repeated step testing to determine their vestibular time constant. The number of anti-motion sickness clinic visits and scopolamine prescriptions was also recorded in the three months period following the intervention.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05004818
Study type	Interventional
Source	Medical Corps, Israel Defense Force
Contact
Status	Completed
Phase	N/A
Start date	August 1, 2016
Completion date	July 1, 2019

View Details

See also
Status	Clinical Trial	Phase
Enrolling by invitation	`NCT04196933` - Analysis of Vestibular Compensation Following Clinical Intervention for Vestibular Schwannoma	N/A
Recruiting	`NCT06128707` - Vestibulo-Ocular Reflex Function in Individuals With Chronic Motion Sensitivity Cross-Sectional Study
Completed	`NCT05611814` - Preliminary Evaluation of an Osteopathic Manipulative Treatment (OMT) to Prevent Motion Sickness Symptoms	N/A
Recruiting	`NCT06106256` - Three-Axis Wearable Adaptive Vestibular Stimulator	N/A
Completed	`NCT02839135` - A Comparative Bioavailability and Adhesion Performance Study, Comparing a New Scopolamine Transdermal Delivery System Formulation to the Currently Established Reference Transdermal Delivery System in Healthy Adult Participants.	Phase 1
Completed	`NCT04420949` - Sensory Training for Visual Motion Sickness	N/A
Completed	`NCT04184115` - Nasal Gel for the Prevention and Treatment of Nausea Associated With Motion Sickness	Phase 3
Completed	`NCT03988530` - Prevention and Treatment of Nausea Associated With Motion Sickness in Senior Subjects	Phase 3
Terminated	`NCT04219982` - DPI 386 Nasal Gel for the Prevention of Nausea Associated With Motion Sickness	Phase 2/Phase 3
Terminated	`NCT02155309` - Pharmacokinetic and Efficacy Profile Intranasal Scopolamine Spray	Phase 2/Phase 3
Completed	`NCT04947423` - Nasal Gel for the Prevention of Nausea and Vomiting Associated With Motion	Phase 3
Recruiting	`NCT05903924` - Motion Serifos: A Study to Investigate the Efficacy of Tradipitant in Participants Affected by Motion Sickness	Phase 3
Recruiting	`NCT04999449` - Nebulizer Delivery of Intranasal Scopolamine	Phase 1
Recruiting	`NCT05886660` - Combination of Intranasal Scopolamine and Sensory Augmentation to Mitigate G-transition Induced Motion Sickness and Enhance Sensorimotor Performance	Phase 2
Completed	`NCT03755596` - Clinical Evaluation of the Use of Ginger Extract in the Management of Motion Sickness	Phase 4
Recruiting	`NCT05628220` - Motion Sickness Desensitization Using VR	N/A
Recruiting	`NCT06138613` - Motion Delos: An Open Label Safety and Efficacy of Tradipitant in Participants Affected by Motion Sickness	Phase 3
Completed	`NCT04327661` - Motion Syros: A Study to Investigate the Efficacy of Tradipitant in Subjects Affected by Motion Sickness	Phase 3
Completed	`NCT06232785` - Gynecologic Endoscopic Surgery of Female Motion Sickness Patients	Phase 4
Completed	`NCT06056622` - Motion Sickness Rehabilitation for Virtual Reality	N/A